View in EDS

Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.

Saved in:
Bibliographic Details
Title: Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
Authors: Leal CTS; Federal University of Juiz de Fora, Juiz de Fora, Brazil. christianneleal74@gmail.com., Costa LJM; University of Alabama at Birmingham, EUA, Birmingham, AL, USA., Pereira J; São Paulo University, São Paulo, Brazil., Duarte FB; Federal University of Ceará, Fortaleza, Brazil., Tavares RB; Federal University of Juiz de Fora, Juiz de Fora, Brazil., Atalla A; Monte Sinai Hospital, Juiz de Fora, Brazil., Sabioni BS; São José Hospital, Teresópolis, Brazil., Neto AEH; Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2022 Feb; Vol. 57 (2), pp. 309-311. Date of Electronic Publication: 2021 Nov 29.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34845366
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leal+CTS%22">Leal CTS</searchLink>; Federal University of Juiz de Fora, Juiz de Fora, Brazil. christianneleal74@gmail.com.<br /><searchLink fieldCode="AU" term="%22Costa+LJM%22">Costa LJM</searchLink>; University of Alabama at Birmingham, EUA, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Pereira+J%22">Pereira J</searchLink>; São Paulo University, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Duarte+FB%22">Duarte FB</searchLink>; Federal University of Ceará, Fortaleza, Brazil.<br /><searchLink fieldCode="AU" term="%22Tavares+RB%22">Tavares RB</searchLink>; Federal University of Juiz de Fora, Juiz de Fora, Brazil.<br /><searchLink fieldCode="AU" term="%22Atalla+A%22">Atalla A</searchLink>; Monte Sinai Hospital, Juiz de Fora, Brazil.<br /><searchLink fieldCode="AU" term="%22Sabioni+BS%22">Sabioni BS</searchLink>; São José Hospital, Teresópolis, Brazil.<br /><searchLink fieldCode="AU" term="%22Neto+AEH%22">Neto AEH</searchLink>; Federal University of Juiz de Fora, Juiz de Fora, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228702459%22">Bone marrow transplantation</searchLink> [Bone Marrow Transplant] 2022 Feb; Vol. 57 (2), pp. 309-311. <i>Date of Electronic Publication: </i>2021 Nov 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8702459 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202683369%22">02683369 </searchLink><i>NLM ISO Abbreviation: </i>Bone Marrow Transplant <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34845366
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41409-021-01531-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 309
    Titles:
      – TitleFull: Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leal CTS
      – PersonEntity:
          Name:
            NameFull: Costa LJM
      – PersonEntity:
          Name:
            NameFull: Pereira J
      – PersonEntity:
          Name:
            NameFull: Duarte FB
      – PersonEntity:
          Name:
            NameFull: Tavares RB
      – PersonEntity:
          Name:
            NameFull: Atalla A
      – PersonEntity:
          Name:
            NameFull: Sabioni BS
      – PersonEntity:
          Name:
            NameFull: Neto AEH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5365
          Numbering:
            – Type: volume
              Value: 57
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Bone marrow transplantation
              Type: main
ResultId 1